EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
15.53
-0.01 (-0.06%)
At close: Jan 21, 2026, 4:00 PM EST
15.53
0.00 (0.00%)
After-hours: Jan 21, 2026, 4:31 PM EST

EyePoint Market Cap

EyePoint has a market cap or net worth of $1.28 billion as of January 21, 2026. Its market cap has increased by 133.59% in one year.

Market Cap
1.28B
Enterprise Value
1.07B
1-Year Change
133.59%
Ranking
Category
Stock Price
$15.53

Market Cap Chart

Since January 27, 2005, EyePoint's market cap has increased from $388.60M to $1.28B, an increase of 229.47%. That is a compound annual growth rate of 5.84%.

History

DateMarket Cap% Change
Jan 20, 20261.29B-14.94%
Dec 31, 20251.51B197.44%
Dec 31, 2024508.50M-37.68%
Dec 29, 2023816.00M583.99%
Dec 30, 2022119.30M-66.13%
Dec 31, 2021352.20M273.09%
Dec 31, 202094.40M-43.68%
Dec 31, 2019167.60M-6.53%
Dec 31, 2018179.30M266.67%
Dec 29, 201748.90M-16.27%
Dec 30, 201658.40M-58.82%
Dec 31, 2015141.80M17.58%
Dec 31, 2014120.60M12.71%
Dec 31, 2013107.00M279.43%
Dec 31, 201228.20M22.08%
Dec 30, 201123.10M-75.61%
Dec 31, 201094.70M44.14%
Dec 31, 200965.70M281.98%
Dec 31, 200817.20M-70.19%
Dec 31, 200757.70M-25.93%
Dec 29, 200677.90M-62.73%
Dec 30, 2005209.00M-46.22%
Jan 27, 2005388.60M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company929.76B
Johnson & Johnson526.82B
AbbVie378.84B
UnitedHealth Group299.85B
AstraZeneca289.32B
Novartis AG278.23B
Merck & Co.270.12B
Novo Nordisk261.50B
Market Cap Rankings